Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Health tech companies made several major funding announcements in September. Here is a list of some of the biggest funding rounds.
EliseAI raises $350 million in funding
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
EliseAI, based in New York, is a company working to automate housing and healthcare systems. Its AI agents automate leasing, maintenance, renewals, billing, patient scheduling, intake and front-desk workflows.
The financing round was led by Andreessen Horowitz (a16z) and Bessemer Venture Partners, with participation from Ontario Teachers’ Pension Plan, Sapphire Ventures and Navitas Capital. The company is now valued at $4 billion.
Rightway rakes in $155 million in Series E funding
New York City-based Rightway is a pharmacy benefit management and care navigation company. It serves both employers and health systems, including 45 Fortune 500 companies. It offers a 100% pass-through PBM model, in which all rebates and discounts negotiated with pharmacies and drug manufacturers are passed back to employers.
Closing the Quality-Affordability Gap in Workplace Mental Health
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.
The Series E round was led by Francisco Partners, with participation from Thrive Capital and Khosla Ventures. The financing will be used to expand its AI capabilities and technology, according to the announcement.
Forus raises $150 million in Series C funding
Forus, previously known as Tandem, offers a platform that connects doctors, pharmacies, payers and biopharma. The company uses AI agents to handle the administrative work between a provider prescribing a medication and a patient starting treatment, including navigating insurance, financial assistance and pharmacy logistics. Providers in all 50 states use the platform to treat patients in 85% of U.S. residential zip codes, according to the announcement.
The $150 million Series C round was led by Bain Capital Ventures, with participation from Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Avra, Human Capital, Neo, Vast Ventures and SV Angel. In total, Forus has raised more than $300 million.
Thyme Care secures $125 million in Series E funding
Nashville, Tennessee-based Thyme Care, founded in 2020, partners with health plans, employers and risk-bearing providers to support patients battling cancer. It offers care navigation services, technology and data insights and therapeutic interventions. The company helps patients understand their diagnosis, find a cancer doctor and receive clinical care between appointments. Patients also gain access to a team of providers, nurses and resource specialists. Its services are available to 10.5 million people across all 50 states.
The Series E round was led by Morgan Health and included participation from Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures and a16z Bio + Health. The company is now valued at more than $2 billion.
Photo: Andriy Onufriyenko, Getty Images